Although the predictive performance based on transcriptomic data is modest (AUC ∼0.7), which limits immediate clinical applicability, the reproducibility of our mechanistic findings—supported by prior evidence in other cancer types—suggests that RBCK1 may serve as a valuable component of a broader predictive framework. The gene discussed is RBCK1; the disease is cancer.